Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 03 - 25 save search
Windtree Therapeutics Announces Closing of $30.0 Million Public Offering
Published: 2021-03-25 (Crawled : 22:00) - biospace.com/
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -3.88%
H: 5.38%
C: 4.48%
offering therapeutics publication
Relay Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Published: 2021-03-25 (Crawled : 22:00) - biospace.com/
RLAY | $5.96 -2.46% -2.52% 2.4M
|
Health Technology
|
| O: -0.43%
H: 3.3%
C: 1.92%
financial results results
4D Molecular Therapeutics Reports Financial Results for the Year Ended December 31, 2020 and Provides Operational Highlights
Published: 2021-03-25 (Crawled : 22:00) - biospace.com/
FDMT M | $25.29 2.06% 2.02% 630K
|
Health Technology
|
| O: -1.78%
H: 6.59%
C: 0.61%
financial results results molecular
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
Published: 2021-03-25 (Crawled : 22:00) - globenewswire.com
VVOS | $2.72 2.26% 2.21% 34K
|
Health Technology
|
| O: 9.65%
H: 0.0%
C: -7.87%
financial results results
Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares
Published: 2021-03-25 (Crawled : 22:00) - globenewswire.com
GANX | $3.155 0.16% 0.16% 71K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 10.18%
C: 8.42%
offering
Sorrento Announces Updated Positive Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
Published: 2021-03-25 (Crawled : 21:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -3.55%
H: 7.49%
C: 5.9%
covid treatment positive results phase 1 positive results phase 1b phase 2b
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
Published: 2021-03-25 (Crawled : 21:00) - globenewswire.com
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -0.98%
H: 5.85%
C: 5.79%
TRVN | $0.35 -4.37% -4.57% 170K
|
Health Technology
|
| O: 0.53%
H: 0.53%
C: -2.66%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.48%
H: 1.31%
C: -1.66%
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.25%
H: 0.62%
C: -3.92%
financial results results therapeutics
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
Published: 2021-03-25 (Crawled : 21:00) - globenewswire.com
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 4.05%
H: 0.46%
C: -5.03%
financial results results
CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Published: 2021-03-25 (Crawled : 21:00) - globenewswire.com
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 2.4%
H: 1.26%
C: -4.47%
financial results results
Trevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates
Published: 2021-03-25 (Crawled : 20:00) - ir.trevitherapeutics.com
TRVI | $2.82 5.03% 4.79% 140K
|
Health Technology
|
| O: 2.38%
H: 6.2%
C: 5.04%
financial results results
Anisha Wharton
Published: 2021-03-25 (Crawled : 19:00) - aveooncology.com
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.02%
H: 2.85%
C: -1.62%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.65%
H: 1.04%
C: -3.64%
Chemical Informatics and Laboratory Automation Specialist
Published: 2021-03-25 (Crawled : 17:00) - nurixtx.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.52%
H: 5.7%
C: 4.48%
Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics
Published: 2021-03-25 (Crawled : 15:15) - biospace.com/
PRTG | $0.28 16.67% 14.29% 280K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.59%
H: 0.0%
C: -3.4%
phase 2 cancer biotech iot breast cancer trial
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals
Published: 2021-03-25 (Crawled : 14:00) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: -1.55%
H: 2.71%
C: -0.29%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.45%
H: 4.52%
C: 3.17%
biopharma patent
Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of DirectorsRefreshed board to bring fresh perspectives, relevant expertise and diverse experience
Published: 2021-03-25 (Crawled : 13:15) - biospace.com/
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: -6.36%
H: 17.24%
C: 16.08%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -1.12%
H: 9.66%
C: 6.82%
Akebia Therapeutics Announces Poster Presentations and Educational Symposium at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
Published: 2021-03-25 (Crawled : 13:15) - biospace.com/
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: -1.96%
H: 8.33%
C: 8.0%
presentation education kidney symposium
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
Published: 2021-03-25 (Crawled : 13:15) - prnewswire.com
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.24%
H: 0.25%
C: -0.46%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.44%
H: 1.64%
C: 1.13%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -3.25%
H: 5.48%
C: 4.71%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.05%
H: 3.56%
C: 1.09%
covid vaccine research covid-19
Cyclo Therapeutics Meets Primary Efficacy Endpoint in Phase 1/2 Trial from Intravenous Trappsol® Cyclo™ in Rare Disease Niemann-Pick Type C1 (NPC1)
Published: 2021-03-25 (Crawled : 13:15) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 10.4%
H: 2.73%
C: -25.62%
disease phase 1 trial phase 3 phase 2 rare
Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease
Published: 2021-03-25 (Crawled : 13:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: -2.27%
H: 9.49%
C: 8.61%
disease guggenheim healthcare genomic rare
Aquestive Therapeutics Successfully Demonstrates Repeatable and Predictable Oral Sublingual Film Administration of Epinephrine
Published: 2021-03-25 (Crawled : 13:00) - globenewswire.com
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
|
| O: -2.29%
H: 7.63%
C: 5.4%
epinephrine
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.